Hua Wang

5PUBLICATIONS
9CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Models of care and place of birth
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 23, 2025
Clinical Outcome of Extramedullary Multiple Myeloma in the Era of Novel Agents: Insights From a Multicenter Study.

Dong Liang, Yurong Yan, Qiaoli Wang

|Apr 30, 2025
Clinical outcome of ≥2% circulating tumor cells in newly diagnosed multiple myeloma: insights from a multicenter study.

Dong Liang, Yurong Yan, Shenrui Bai

|Oct 18, 2024
Clinical Outcome of Induction Treatment in the Era of Novel Agents and the Impact of the Number of High-Risk Cytogenetic Abnormalities (HRA) on Prognosis of Patients With Newly Diagnosed Multiple Myeloma (NDMM): Insights From a Multicenter Study.

Dong Liang, Xiaojin Li, Shenrui Bai

|Jul 07, 2020
Pegaspargase Combined with Concurrent Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Two-Center Phase II Study.

Hua Wang, Liang Wang, Chun Li

|Jul 20, 2019
Long-term outcomes of modified BFM-95 regimen in adults with newly diagnosed standard-risk acute lymphoblastic leukemia: a retrospective single-center study.

Chun Li, Xiuyu Cai, Xiaoqin Chen

Pageof 1

Frequent Collaborators

3 joint publications

Dong Liang

2 joint publications

Shenrui Bai

2 joint publications

Demei Feng

2 joint publications

Fengyan Jin